Molina Healthcare (NYSE:MOH) had its target price boosted by research analysts at Leerink Swann from $100.00 to $105.00 in a report released on Tuesday. The firm currently has an “outperform” rating on the stock. Leerink Swann’s target price points to a potential upside of 22.58% from the stock’s previous close.
Other equities research analysts have also recently issued reports about the company. Jefferies Group increased their price objective on Molina Healthcare from $60.00 to $64.00 and gave the company a “hold” rating in a research report on Friday, October 13th. Wolfe Research raised Molina Healthcare from a “market perform” rating to an “outperform” rating in a research report on Monday, October 23rd. Morgan Stanley increased their price objective on Molina Healthcare from $68.00 to $89.00 and gave the company an “overweight” rating in a research report on Friday, November 3rd. Zacks Investment Research raised Molina Healthcare from a “hold” rating to a “strong-buy” rating and set a $88.00 price objective for the company in a research report on Tuesday, January 2nd. Finally, Raymond James Financial reissued a “hold” rating on shares of Molina Healthcare in a research report on Friday, December 8th. Three investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $70.03.
Molina Healthcare (MOH) traded up $2.93 on Tuesday, hitting $85.66. The stock had a trading volume of 2,119,028 shares, compared to its average volume of 1,192,305. Molina Healthcare has a 12 month low of $42.56 and a 12 month high of $86.39. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 1.06. The company has a market capitalization of $4,720.00, a PE ratio of -16.25, a price-to-earnings-growth ratio of 1.08 and a beta of 0.97.
In other Molina Healthcare news, insider William Dentino sold 67,500 shares of Molina Healthcare stock in a transaction on Monday, October 16th. The stock was sold at an average price of $61.49, for a total transaction of $4,150,575.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director John C. Molina sold 23,993 shares of Molina Healthcare stock in a transaction on Wednesday, October 18th. The shares were sold at an average price of $62.55, for a total value of $1,500,762.15. Following the transaction, the director now directly owns 517,529 shares of the company’s stock, valued at $32,371,438.95. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 724,445 shares of company stock valued at $52,790,963. 6.20% of the stock is owned by company insiders.
Several hedge funds and other institutional investors have recently modified their holdings of the business. Jana Partners LLC lifted its holdings in shares of Molina Healthcare by 52.5% during the third quarter. Jana Partners LLC now owns 2,125,351 shares of the company’s stock valued at $146,139,000 after acquiring an additional 731,992 shares during the period. Pura Vida Investments LLC bought a new position in shares of Molina Healthcare during the third quarter valued at $1,719,000. Sterling Capital Management LLC lifted its holdings in shares of Molina Healthcare by 16.4% during the third quarter. Sterling Capital Management LLC now owns 24,946 shares of the company’s stock valued at $1,715,000 after acquiring an additional 3,516 shares during the period. Neuberger Berman Group LLC lifted its holdings in shares of Molina Healthcare by 23.0% during the third quarter. Neuberger Berman Group LLC now owns 533,021 shares of the company’s stock valued at $36,651,000 after acquiring an additional 99,543 shares during the period. Finally, California Public Employees Retirement System lifted its holdings in shares of Molina Healthcare by 12.7% during the third quarter. California Public Employees Retirement System now owns 79,204 shares of the company’s stock valued at $5,446,000 after acquiring an additional 8,904 shares during the period. 96.22% of the stock is owned by institutional investors.
TRADEMARK VIOLATION WARNING: This piece was published by American Banking and Market News and is the sole property of of American Banking and Market News. If you are reading this piece on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2018/01/09/molina-healthcare-moh-price-target-raised-to-105-00.html.
About Molina Healthcare
Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.
